Expanding the use of primaquine for the radical cure of Plasmodium vivax

There is currently strong impetus for global malaria eradication with many National Malaria Control Programs setting ambitious elimination targets. Whilst intensified malaria control efforts have reduced the burden of falciparum malaria significantly, the fragile gains made thus far remain vulnerabl...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Price, RN, Douglas, NM
Materialtyp: Journal article
Språk:English
Publicerad: Oxford University Press 2018
_version_ 1826304276428750848
author Price, RN
Douglas, NM
author_facet Price, RN
Douglas, NM
author_sort Price, RN
collection OXFORD
description There is currently strong impetus for global malaria eradication with many National Malaria Control Programs setting ambitious elimination targets. Whilst intensified malaria control efforts have reduced the burden of falciparum malaria significantly, the fragile gains made thus far remain vulnerable to the threat of emergence and spread of multidrug resistant parasites. Outside of Sub-Saharan Africa, the decline in falciparum malaria has also been shadowed by a rise in the proportion of malaria due to P. vivax, which is now the predominant cause of malaria in these regions. Vivax malaria is more difficult to eradicate than P. falciparum because it can form dormant liver stages (hypnozoites) that reactivate periodically, causing recurrent infections (relapses) and further transmission.
first_indexed 2024-03-07T06:15:20Z
format Journal article
id oxford-uuid:f0e6861b-1aa0-4ee6-b2dc-00a8b10f3e47
institution University of Oxford
language English
last_indexed 2024-03-07T06:15:20Z
publishDate 2018
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:f0e6861b-1aa0-4ee6-b2dc-00a8b10f3e472022-03-27T11:51:38ZExpanding the use of primaquine for the radical cure of Plasmodium vivaxJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f0e6861b-1aa0-4ee6-b2dc-00a8b10f3e47EnglishSymplectic Elements at OxfordOxford University Press2018Price, RNDouglas, NMThere is currently strong impetus for global malaria eradication with many National Malaria Control Programs setting ambitious elimination targets. Whilst intensified malaria control efforts have reduced the burden of falciparum malaria significantly, the fragile gains made thus far remain vulnerable to the threat of emergence and spread of multidrug resistant parasites. Outside of Sub-Saharan Africa, the decline in falciparum malaria has also been shadowed by a rise in the proportion of malaria due to P. vivax, which is now the predominant cause of malaria in these regions. Vivax malaria is more difficult to eradicate than P. falciparum because it can form dormant liver stages (hypnozoites) that reactivate periodically, causing recurrent infections (relapses) and further transmission.
spellingShingle Price, RN
Douglas, NM
Expanding the use of primaquine for the radical cure of Plasmodium vivax
title Expanding the use of primaquine for the radical cure of Plasmodium vivax
title_full Expanding the use of primaquine for the radical cure of Plasmodium vivax
title_fullStr Expanding the use of primaquine for the radical cure of Plasmodium vivax
title_full_unstemmed Expanding the use of primaquine for the radical cure of Plasmodium vivax
title_short Expanding the use of primaquine for the radical cure of Plasmodium vivax
title_sort expanding the use of primaquine for the radical cure of plasmodium vivax
work_keys_str_mv AT pricern expandingtheuseofprimaquinefortheradicalcureofplasmodiumvivax
AT douglasnm expandingtheuseofprimaquinefortheradicalcureofplasmodiumvivax